| John Raymond Durant, MD | |
|
301 Mariarden Rd, Ste D, Dadeville, AL 36853-0129 | |
| (256) 825-7871 | |
| (256) 825-5742 |
| Full Name | John Raymond Durant |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 301 Mariarden Rd, Dadeville, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790717858 | NPI | - | NPPES |
| 543420001 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 19640 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Martin Community Hospital | Dadeville, AL | Hospital |
| East Alabama Medical Center And Snf | Opelika, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ivy Creek Family Care Of Lake Martin | 6103281977 | 8 |
| Ivy Creek Of Tallapoosa Llc | 8123938719 | 11 |
News Archive
The number of states in which at least 35% of residents are obese has nearly doubled since 2018 – and disparities persist – according to new data from the Centers for Disease Control and Prevention.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2's funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal of supplementing Agios's ongoing research into the development of new IDH1 therapeutics and diagnostics.
On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome.
A pre-clinical study led by Indiana University scientists reports a promising step forward in the search for pain relief methods without the addictive side effects behind the country's current opioid addiction crisis.
› Verified 6 days ago
| Entity Name | Ivy Creek Of Tallapoosa Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130002 PECOS PAC ID: 8123938719 Enrollment ID: O20031229000288 |
News Archive
The number of states in which at least 35% of residents are obese has nearly doubled since 2018 – and disparities persist – according to new data from the Centers for Disease Control and Prevention.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2's funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal of supplementing Agios's ongoing research into the development of new IDH1 therapeutics and diagnostics.
On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome.
A pre-clinical study led by Indiana University scientists reports a promising step forward in the search for pain relief methods without the addictive side effects behind the country's current opioid addiction crisis.
› Verified 6 days ago
| Entity Name | Ivy Creek Family Care Of Lake Martin |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609572890 PECOS PAC ID: 6103281977 Enrollment ID: O20230501000230 |
News Archive
The number of states in which at least 35% of residents are obese has nearly doubled since 2018 – and disparities persist – according to new data from the Centers for Disease Control and Prevention.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2's funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal of supplementing Agios's ongoing research into the development of new IDH1 therapeutics and diagnostics.
On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome.
A pre-clinical study led by Indiana University scientists reports a promising step forward in the search for pain relief methods without the addictive side effects behind the country's current opioid addiction crisis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Raymond Durant, MD Po Box 129, Dadeville, AL 36853-0129 Ph: (256) 825-7871 | John Raymond Durant, MD 301 Mariarden Rd, Ste D, Dadeville, AL 36853-0129 Ph: (256) 825-7871 |
News Archive
The number of states in which at least 35% of residents are obese has nearly doubled since 2018 – and disparities persist – according to new data from the Centers for Disease Control and Prevention.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2's funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal of supplementing Agios's ongoing research into the development of new IDH1 therapeutics and diagnostics.
On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome.
A pre-clinical study led by Indiana University scientists reports a promising step forward in the search for pain relief methods without the addictive side effects behind the country's current opioid addiction crisis.
› Verified 6 days ago
Mr. Robert William Bartel, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 301 Mariarden Rd, Dadeville, AL 36853 Phone: 256-825-7164 Fax: 256-827-0808 | |
Robert Alan Schuster, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 301 Mariarden Rd, Ste D, Dadeville, AL 36853 Phone: 256-825-7871 Fax: 256-825-5742 |